The Molecular Basis of Autoantibody Pathogenicity

increasing volume of use. While bureaucracy may succeed in integratrion on the supply side, national differences in the nature of the client means that demand will remain highly variable for a very long time. Mrs F Charlesworth (ABPI, London, UK) pointed out that while it was the aim of the Community to complete the single market with effect from 1 January 1993, medicines and medical treatments have proved more resistant to the concept than many other types of product. Although the Maastricht Treaty envisaged cooperation between Member States on healthcare issues, it did not lay the foundation of a Community Healthcare Policy, and the costs of provision of health care services continue to be a domestic issue in each Member State.

[1]  Ralph C. Williams.  Natural autoantibodies: their physiological role and regulatory significance. Edited by Yehuda Shoenfeld and David A. Isenberg. Boca Raton, CRC Press, 1993. 355 PP. Illustrated. Indexed. $159.95 , 1994 .

[2]  D. Isenberg,et al.  Identification of the 9G4 idiotope in systemic lupus erythematosus. , 1993, British journal of rheumatology.

[3]  A. Vincent,et al.  Presentation of endogenous acetylcholine receptor epitope by an MHC class II-transfected human muscle cell line to a specific CD4+ T cell clone from a myasthenia gravis patient , 1993, Journal of Neuroimmunology.

[4]  A. Vincent,et al.  Approaches for Studying the Pathogenic T Cells in Autoimmune Patients a , 1993, Annals of the New York Academy of Sciences.

[5]  A. Vincent,et al.  Pathogenic autoimmunity to affinity‐purified mouse acetylcholine receptor induced without adjuvant in BALB/c mice , 1993, European journal of immunology.

[6]  A. Cooke,et al.  Active suppression induced by anti‐CD4 , 1993, European journal of immunology.

[7]  D. Isenberg,et al.  Primary sequence and location of the idiotopes of V-88, a DNA-binding monoclonal autoantibody, determined by idiotope scanning with synthetic peptides on pins. , 1993, Immunology.

[8]  M. Madaio,et al.  Independently derived murine glomerular immune deposit-forming anti-DNA antibodies are encoded by near-identical VH gene sequences. , 1993, The Journal of clinical investigation.

[9]  D. Isenberg,et al.  Production of human monoclonal antibodies to myeloperoxidase. , 1992, Immunology.

[10]  M. Madaio,et al.  Anti-DNA antibodies form immune deposits at distinct glomerular and vascular sites. , 1992, Kidney international.

[11]  B. Leaker,et al.  Production and characterization of mouse monoclonal antibodies to native human myeloperoxidase. , 1992, Hybridoma.

[12]  M. Madaio,et al.  Variable region sequence analysis of anti-DNA antibodies: evidence for a family of closely related germ-line VH genes encoding lupus autoantibodies. , 1992, DNA and cell biology.

[13]  M. Madaio,et al.  Murine monoclonal anti-DNA antibodies penetrate cells, bind to nuclei, and induce glomerular proliferation and proteinuria in vivo. , 1992, Journal of the American Society of Nephrology : JASN.

[14]  P. Ohashi.  Ablation of ‘tolerance’ and induction of diabetes by virus infection in viral antigen transgenic mice , 1991 .

[15]  B. Diamond,et al.  Antibodies elicited by pneumococcal antigens bear an anti-DNA--associated idiotype. , 1991, The Journal of clinical investigation.

[16]  R. Goldschmeding,et al.  Autoimmunity to lysosomal enzymes: new clues to vasculitis and glomerulonephritis? , 1991, Immunology today.